An aptamer targeting shared tumor-specific peptide antigen of MAGE-A3 in multiple cancers

Nucleic Acid Aptamers: New Methods for Selection, Stabilization, and Application in Biomedical Science

(2014) Hoon Young Kong et al.   Biomolecules & Therapeutics

Adjuvant MAGE-A3 Immunotherapy in Resected Non–Small-Cell Lung Cancer: Phase II Randomized Study Results

(2013) Johan Vansteenkiste et al.   JOURNAL OF CLINICAL ONCOLOGY

CrossTope: a curate repository of 3D structures of immunogenic peptide: MHC complexes

(2013) Marialva Sinigaglia et al.   Database-The Journal of Biological Databases and Curation

MAGE-A antigens as targets in tumour therapy

(2012) David W. Meek et al.   CANCER LETTERS

Nucleic acid aptamers: an emerging frontier in cancer therapy

(2012) Guizhi Zhu et al.   CHEMICAL COMMUNICATIONS

A Dynamic FRET Reporter of Gene Expression Improved by Functional Screening

(2012) Martina Schifferer et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Genomic modulators of the immune response

(2012) Julian C. Knight   TRENDS IN GENETICS

Molecular Imaging with Nucleic Acid Aptamers

(2011) H. Hong et al.   CURRENT MEDICINAL CHEMISTRY

Vaccines for the treatment of non-small cell lung cancer: Investigational approaches and clinical experience

(2011) Håkan Mellstedt et al.   LUNG CANCER

Expression profile of cancer-testis genes in transitional cell carcinoma of the bladder

(2011) Bo Yin et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

MAGE-A family: Attractive targets for cancer immunotherapy

(2011) Meixiang Sang et al.   VACCINE

Nucleic acid-based fluorescent probes and their analytical potential

(2010) Bernard Juskowiak   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia

(2010) O. Goodyear et al.   BLOOD

MAGE-A3 and MAGE-A4 specific CD4+ T cells in head and neck cancer patients: detection of naturally acquired responses and identification of new epitopes

(2010) Valérie Cesson et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research

(2009) M. A. Cheever et al.   CLINICAL CANCER RESEARCH

The cancer vaccine roller coaster

(2009) Bruce Goldman et al.   NATURE BIOTECHNOLOGY

Cancer immunotherapy targeting tumour-specific antigens: towards a new therapy for minimal residual disease

(2008) Vincent G Brichard et al.   EXPERT OPINION ON BIOLOGICAL THERAPY